"Right now, the longest-term studies are the WATER trials, which have published 5-year outcomes. But we know that a subset of men will require retreatment over time," says Claire S. Burton, MD.
In this video, Claire S. Burton, MD, discusses further research needed from the study, “Outcomes of Aquablation in men with acute and chronic urinary retention,” for which she served as the lead author. Burton is an FPMRS fellow at Standford University in California.
Video Transcript:
I think what we continue to need is longer term follow-up. Right now, the longest-term studies are the WATER trials, which have published 5-year outcomes. But we know that a subset of men will require retreatment over time, and so I think longer follow-up. In our sample, the mean follow-up was 6 months. We know that some men will need to go back on prostate medications or will need to have retreatment over time and our follow-up is likely too short to reflect those long-term differences. We did find that less than 10% of our patients went back on prostate medication use at their time of follow-up, which was pretty consistent with what was in the WATER trials and also what we expect in the TURP literature as well.
This transcription has been edited for clarity.
Study examines patient knowledge of urinary tract infections
July 11th 2024"The objective of this study was to assess baseline knowledge about urinary tract infections, interest in health resources, and platform preferences for health information acquisition and dissemination," says Stephanie Gleicher, MD.
Destigmatizing Urology: Dr. Winter discusses STDs/STIs
March 22nd 2022“We need to just approach STIs as the medical conditions they are because until we do, and until we take those stigmas away, people will truly have resistance to discussing it, hesitance to discussing it, and resistance to diagnosis and intervention,” says Ashley Winter, MD.
Burden of care for recurrent UTI is higher for female urologists
June 15th 2024"What we believe is happening is women are seeking the help of female urologists, and therefore, because of the nature of the condition, the female urologists are absorbing the burden of the care of these patients, particularly the non-billable burden," says Debra L. Fromer, MD.
Predictive model quantifies risk of antibiotic resistance in uUTI
May 24th 2024The predictive models identified the number of previous UTI episodes, prior β-lactam nonsusceptibility, prior fluoroquinolone treatment, Census Bureau region (particularly in the South), and race as key predictors of having a non-susceptible isolate to 3 or more antibiotic classes.